Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosisSCHAECHER, Scott R; TOUCHETTE, Erin; SCHRIEWER, Jill et al.Journal of virology. 2007, Vol 81, Num 20, pp 11054-11068, issn 0022-538X, 15 p.Article

Soft-X-Ray-Enhanced Electrostatic Precipitation for Protection against Inhalable Allergens, Ultrafine Particles, and Microbial InfectionsKETTLESON, Eric M; SCHRIEWER, Jill M; BULLER, R. Mark L et al.Applied and environmental microbiology (Print). 2013, Vol 79, Num 4, pp 1333-1341, issn 0099-2240, 9 p.Article

A Mouse Model of Lethal Infection for Evaluating Prophylactics and Therapeutics against Monkeypox VirusSTABENOW, Jennifer; BULLER, R. Mark; SCHRIEWER, Jill et al.Journal of virology. 2010, Vol 84, Num 8, pp 3909-3920, issn 0022-538X, 12 p.Article

2'- O methylation of the viral mRNA cap evades host restriction by IFIT family membersDAFFIS, Stephane; SZRETTER, Kristy J; THIEL, Volker et al.Nature (London). 2010, Vol 468, Num 7322, pp 452-456, issn 0028-0836, 5 p.Article

VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response aloneMOISE, Leonard; BULLER, R. Mark; SCHRIEWER, Jill et al.Vaccine. 2011, Vol 29, Num 3, pp 501-511, issn 0264-410X, 11 p.Article

An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challengeGUANG YANG; PEVEAR, Daniel C; HUGGINS, John W et al.Journal of virology. 2005, Vol 79, Num 20, pp 13139-13149, issn 0022-538X, 11 p.Article

Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in miceHOSTETLER, Karl Y; BEADLE, James R; TRAHAN, Julissa et al.Antiviral research. 2007, Vol 73, Num 3, pp 212-218, issn 0166-3542, 7 p.Article

Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challengeEMPIG, Cyril; KENNER, Julie R; SCHRIEWER, Jill et al.Vaccine. 2006, Vol 24, Num 17, pp 3686-3694, issn 0264-410X, 9 p.Article

Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001PARKER, Scott; SCHRIEWER, Jill; OBERLE, Christina et al.Antiviral therapy (London). 2008, Vol 13, Num 7, pp 863-873, issn 1359-6535, 11 p.Article

Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virusPARKER, Scott; CRUMP, Ryan; FOSTER, Scott et al.Antiviral research. 2014, Vol 111, pp 42-52, issn 0166-3542, 11 p.Article

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - An animal model of smallpoxPARKER, Scott; CHEN, Nanhai G; SAGARTZ, John E et al.Antiviral research. 2012, Vol 94, Num 1, pp 44-53, issn 0166-3542, 10 p.Article

The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virusDENZLER, Karen L; SCHRIEWER, Jill; PARKER, Scott et al.Vaccine. 2011, Vol 29, Num 52, pp 9691-9696, issn 0264-410X, 6 p.Article